End-User Analysis: The Dominance of Hospitals and Clinics in Revenue

Within the Thumb Arthritis Market’s end-user segmentation, the Hospitals & Clinics category is the largest revenue generator, significantly overshadowing Retail Pharmacies. This dominance is rooted in the centralization of capital-intensive diagnostics and high-cost surgical treatments within these specialized healthcare facilities, making them the primary point of revenue for medical device and imaging companies.

Hospitals are the exclusive settings for advanced diagnostic procedures, utilizing specialized Imaging equipment (X-ray, MRI, etc.) supplied by vendors like General Electric Company, which are necessary for confirming the severity of Osteoarthritis (OA). More critically, all definitive surgical procedures, including joint replacement and arthrodesis, are performed in hospital settings, requiring high-value surgical consumables and long patient stays, resulting in significant revenue generation.

Furthermore, hospitals and specialized clinics serve as major distribution points for high-cost Medication, particularly for the delivery of steroid injections and intravenous biologics used to manage severe cases of both OA and Rheumatoid Arthritis (RA). The comprehensive, multidisciplinary care model—involving orthopedic surgeons, rheumatologists, and physical therapists—is centralized in these institutions.

While retail pharmacies generate high volumes from chronic drug prescriptions and braces, the massive revenue associated with capital equipment, diagnostics, and surgical interventions ensures that hospitals and clinics will maintain their lead in the market’s end-user segment, driving the overall market growth at an 8.48% CAGR. For a deeper analysis of end-user market dynamics, consult the full report at Thumb Arthritis End-User Analysis.

Tags: #HospitalsAndClinics #EndUserRevenue #RetailPharmacies #SurgicalCenters #HealthcareFacilities